查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1470905

止血劑市場：按類型、配方和應用分類 - 2024-2030 年全球預測

Hemostats Market by Type (Collagen-Based Hemostats, Combination Hemostats, Gelatin-Based Hemostats), Formulation (Matrix & Gel Hemostats, Powder Hemostats, Sheet & Pad Hemostats), Application - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 192 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計2023年止血劑市場規模為32.3億美元，預計2024年將達34.2億美元，2030年將達47.5億美元，複合年成長率為5.65%。

止血劑是各種醫療設備和產品，旨在控制、預防和止血手術和創傷過程中的出血。這些醫療設備在控制出血、促進組織正常癒合、同時降低併發症風險方面發揮重要作用。止血劑在許多外科專業中都有應用，包括心血管外科、一般外科、整形外科、神經外科、婦科外科和牙科外科。與人口老化相關的慢性病的增加增加了對需要有效止血解決方案的手術的需求，導致各種止血劑的使用增加。此外，人們對微創手術的日益青睞，以及政府機構和醫療機構為改善手術基礎設施而增加的投資，也增加了止血劑的使用。與開發創新產品相關的高昂研發成本以及止血劑污染的高風險正在阻礙市場成長。市場供應商不斷開拓生物相容性止血劑，提供有效的出血控制，同時最大限度地減少副作用，預計將創造市場成長機會。

主要市場統計
基準年[2023] 32.3億美元
預測年份 [2024] 34.2億美元
預測年份 [2030] 47.5億美元
複合年成長率（%） 5.65%

由於減少型出血的有效性提高，合併止血劑的使用增加

膠原蛋白止血劑源自精製的膠原蛋白，以其優異的生物相容性和透過引發血小板凝集促進血栓形成的能力而聞名。這些止血劑是涉及軟組織和脆弱結構的手術的首選，例如神經外科手術和眼科手術。複方止血劑由兩種或多種活性劑組成，它們協同作用以增強止血功效。一般來說，產品結合了膠原蛋白、明膠和凝血酶等止血劑的優點。由於複合止血劑在減少複雜手術過程中出血併發症的有效性不斷提高，因此對複合止血劑的需求不斷增加。氧化再生纖維素止血劑是由植物來源的纖維素經過氧化再生過程製成的。它具有抗菌特性，透過在血管和周圍組織之間形成物理屏障來有效控制出血。基於 ORC 的止血劑常用於牙科、胃腸道和婦科手術。凝血酶止血劑含有人類或牛凝血酶作為活性成分，可活化凝血連鎖並迅速形成血栓。它對於控制傳統技術無效或不切實際的出血特別有用，例如心血管手術或器官移植。膠原蛋白止血劑具有高度生物相容性，通常是精細手術的首選。聯合止血劑由於協同效應而更加有效。明膠止血劑因其在危急情況下快速凝固血液的能力而受到重視。基於 ORC 的止血劑具有抗菌特性，並為控制出血創建物理屏障，而基於凝血酶的止血劑則激活凝血連鎖并快速形成血栓。

粉末狀止血劑在製定的外科手術過程中控制和預防出血的潛力越來越大。

基質止血劑和凝膠止血劑是生物相容性、可吸收的材料，可促進血栓快速形成。當在手術期間難以施加直接壓力時，例如在微創手術中，這是優選的。粉狀止血劑吸收出血組織中的液體並促進血小板聚集。易於使用，使其適用於各種外科手術，包括一般外科、整形外科、心血管外科和神經外科。止血片和止血墊片是軟性的生物可吸收材料，使其高度適應不規則的傷口表面。用於需要覆蓋大面積且縫合困難的手術。海綿止血劑是一種高吸水性材料，易於成型為各種形狀，適用於不規則的創腔。常用於牙科、口腔外科、神經外科、心血管外科等。基質和凝膠止血劑可在難以到達的區域快速形成凝塊，而粉末止血劑則易於在外科專業中使用。海綿止血劑也為不規則的創腔提供優異的吸收性和成型性。

應用止血劑在心血管手術中的重要角色是防止出血，確保手術效果。

在心血管手術中，有大量的血液流經動脈和靜脈，需要高效率的止血材料來防止出血。止血劑由於其快速作用和實現有效止血的能力而在這些手術中被廣泛優選。在一般外科手術中，止血劑的使用在傷口處理和確保盲腸和疝氣修復等手術期間盡量減少出血方面發揮重要作用。婦科手術通常需要在子宮切除術和子宮肌瘤切除術等精細手術中仔細控制出血。止血劑有效地減少粘連，同時在此類手術過程中提供充分的止血。止血劑是專門為滿足這些需求而設計的，同時保留神經結構。關節重建和骨折融合術等整形外科手術需要強大的止血器來切割緻密的骨骼和結締組織。在包括植皮和皮瓣重組的重組手術中，失血控制對於手術的成功至關重要。在這些情況下，首選止血劑，因為它們與多種組織相容，並且可以有效密封大傷口。與其他應用相比，心血管手術對先進止血劑的需求很高。

區域洞察

先進醫療設施的不斷增加和外科手術數量的增加，特別是在美國、加拿大和巴西，正在推動美洲止血劑市場的成長。根據美國整形外科醫師協會的數據，2022 年總合進行了 1,017,003 例需要使用止血劑的重組手術。加拿大、杜拜、新加坡、日本和英國醫療旅遊的新興趨勢正在擴大微創手術的數量，並為止血劑市場形成一個平台。根據醫療旅遊指數調查 (MTA)，加拿大是首選旅遊目的地之一，吸引了約 1,400 萬名來自其他國家的美國人。醫療設備正在加強歐洲市場。由於醫療保健成本不斷上升以及政府努力實現醫療保健基礎設施現代化，中東和非洲地區提供了充滿希望的成長機會。在沙烏地阿拉伯、阿拉伯聯合大公國和南非等國家，隨著外科手術數量的增加，對有效止血解決方案的需求正在迅速增加。此外，由於政府增加了擴大國內醫療設備製造的資金以及人們對微創手術的認知不斷增強，印度、澳洲、中國和日本正在推動亞太地區的市場成長。

FPNV定位矩陣

FPNV定位矩陣對於評估止血劑市場至關重要。我們檢視與業務策略和產品滿意度相關的關鍵指標，以對供應商進行全面評估。這種深入的分析使用戶能夠根據自己的要求做出明智的決策。根據評估，供應商被分為四個成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市場佔有率分析

市場佔有率分析是一種綜合工具，可以對止血器市場供應商的現狀進行深入而深入的研究。全面比較和分析供應商在整體收益、基本客群和其他關鍵指標方面的貢獻，以便更好地了解公司的績效及其在爭奪市場佔有率時面臨的挑戰。此外，該分析還提供了對該行業競爭特徵的寶貴見解，包括在研究基準年觀察到的累積、分散主導地位和合併特徵等因素。這種詳細程度的提高使供應商能夠做出更明智的決策並制定有效的策略，從而在市場上獲得競爭優勢。

本報告在以下方面提供了寶貴的見解：

1. 市場滲透率：提供有關主要企業所服務的市場的全面資訊。

2. 市場開拓：我們深入研究利潤豐厚的新興市場，並分析其在成熟細分市場的滲透率。

3. 市場多元化：提供有關新產品發布、開拓地區、最新發展和投資的詳細資訊。

4.競爭評估與資訊：對主要企業的市場佔有率、策略、產品、認證、監管狀況、專利狀況、製造能力等進行全面評估。

5. 產品開發與創新：提供對未來技術、研發活動和突破性產品開發的見解。

本報告解決了以下關鍵問題：

1.止血器市場的市場規模與預測是多少？

2.在止血劑市場預測期間內，有哪些產品、細分市場、應用和領域需要考慮投資？

3.止血劑市場的技術趨勢和法規結構是什麼？

4.止血器市場主要廠商的市場佔有率是多少？

5. 進入止血劑市場的適當形式和策略手段是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 慢性病的流行增加了手術介入的需要
      • 微創手術的成長趨勢
    • 抑制因素
      • 產品回收數量增加
    • 機會
      • 基於生物聚合物的一次性止血劑的興起
      • 奈米技術整合止血劑，使其更有效率、更有針對性
    • 任務
      • 使用止血工具和試劑相關的感染和交叉污染的風險
  • 市場區隔分析
    • 類型：由於減少出血的效果改善，擴大了合併止血劑的使用
    • 處方：粉末止血劑在手術介入期間控制和預防出血的潛力不斷成長
    • 應用：止血劑在心血管手術中預防失血、保證手術成功的重要作用
  • 市場擾動分析
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 價格分析
  • 技術分析
  • 專利分析
  • 貿易分析
  • 法規結構分析

第6章止血劑市場：按類型

  • 膠原膠原蛋白止血劑
  • 組合止血器
  • 明膠止血劑
  • 氧化再生纖維素系止血劑
  • 凝血酶止血劑

第7章 止血劑市場：依配方分類

  • 基質和凝膠止血劑
  • 粉末止血劑
  • 片材和墊片止血劑
  • 海綿止血劑

第8章止血劑市場：依應用分類

  • 心血管外科
  • 一般外科
  • 婦科手術
  • 神經外科
  • 整形外科
  • 重組手術

第9章美洲止血劑市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太止血劑市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章 歐洲、中東、非洲止血劑市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • Teleflex 獲得 FDA核准在心臟手術中擴大 QuikClot Control+ 止血裝置的使用
    • 百特推出可吸收止血粉“PERCLOT”
    • Artivion 的 Parcrot 獲得 FDA核准並開始轉移到 Baxter
    • Olympus Europe SE & Co. KG 擴大與 Endoclot 的合作關係，推出止血劑
    • Darling Ingredients 完成對巴西明膠和膠原蛋白製造商 Gelnex 的收購
    • 用於減少嚴重手術出血的幾丁聚醣止血劑已獲得 FDA 批准
    • AdvaMedica 宣布 FDA 批准 Ax-Surgi 手術止血器
    • Medcura 的 LifeGel 可吸收手術止血材料獲得突破性器械稱號
    • MedtronicNekuPowder 內視鏡止血系統獲得美國FDA 批准
    • Hemostasis LLC 完成對 Fiagon Medical Technologies 的收購
  • 戰略分析和建議

第13章競爭產品組合

  • 主要企業簡介
  • 主要產品系列
Product Code: MRR-961BA04A2E36

[192 Pages Report] The Hemostats Market size was estimated at USD 3.23 billion in 2023 and expected to reach USD 3.42 billion in 2024, at a CAGR 5.65% to reach USD 4.75 billion by 2030.

The hemostats are a range of medical devices and products designed to control, prevent, and stop bleeding during surgical procedures and traumatic injuries. These devices play an important role in managing blood loss and facilitate proper tissue healing while reducing the risk of complications. Hemostats have applications in numerous surgical specialties, including cardiovascular surgery, general surgery, orthopedic surgery, neurosurgery, gynecologic surgery, and dental surgery. The growing occurrence of chronic diseases among an aging population drives the demand for surgeries that necessitate effective blood loss management solutions, consequently expanding the utilization of diverse hemostatic agents. Additionally, increasing inclination toward minimally invasive procedures with rising investments by government bodies and healthcare organizations to improve surgical infrastructure is raising the usage of hemostats. High R&D costs associated with developing breakthrough products and a high risk of contamination with hemostats hamper market growth. The increasing development of biologically compatible hemostats by market vendors that minimize adverse effects while providing effective bleeding control is expected to create opportunities for market growth.

KEY MARKET STATISTICS
Base Year [2023] USD 3.23 billion
Estimated Year [2024] USD 3.42 billion
Forecast Year [2030] USD 4.75 billion
CAGR (%) 5.65%

Type: Expanding the use of combination hemostats owing to their enhanced effectiveness in minimizing bleeding

Collagen-based hemostats are derived from purified collagen; they are known for their excellent biocompatibility and ability to accelerate clot formation by initiating platelet aggregation. These hemostats are often preferred in surgeries involving soft tissues and delicate structures, such as neurosurgery and ophthalmic surgery. Combination hemostats consist of two or more active agents that work synergistically to enhance hemostatic efficacy. They typically combine the benefits of hemostats, such as collagen-based, gelatin-based, and thrombin-based products. The demand for combination hemostats is growing due to their increased effectiveness in minimizing bleeding complications during complex surgical procedures. Oxidized regenerated cellulose-based hemostats are made from plant-derived cellulose that undergoes oxidation and regeneration processes. They possess antimicrobial properties and effectively control bleeding by creating a physical barrier between blood vessels and surrounding tissues. ORC-based hemostats are often used in dental surgeries, gastrointestinal surgeries, and gynecological procedures. Thrombin-based hemostats contain human or bovine thrombin as their active ingredient, which activates the coagulation cascade, resulting in rapid clot formation. They are particularly useful in controlling bleeding where traditional techniques may be ineffective or impractical, such as cardiovascular surgeries or organ transplantations. The collagen-based hemostats provide excellent biocompatibility and are often preferred for delicate surgeries. Combination hemostats offer increased effectiveness due to their synergistic properties. Gelatin-based hemostats are valued for their rapid blood clotting ability in critical situations. ORC-based hemostats exhibit antimicrobial properties and create a physical barrier for bleeding control, while thrombin-based hemostats activate the coagulation cascade for rapid clot formation.

Formulation: Growing potential of powder hemostats for controlling and preventing bleeding during surgical intervention

Matrix and gel hemostats are biocompatible, absorbable materials that facilitate rapid clot formation. They are preferred in situations where the application of direct pressure during surgery is difficult, such as in minimally invasive procedures. Powder hemostats work by absorbing fluid from bleeding tissue and enhancing platelet aggregation. Their ease of application makes them suitable for various surgical specialties, including general, orthopedic, cardiovascular, and neurosurgery. Sheet and pad hemostats are flexible bioabsorbable materials, allowing for better conformity to irregular wound surfaces. They are utilized in surgeries where larger areas need to be covered, and suturing is challenging. Sponge hemostats are highly absorbent materials easily molded into various shapes, making them suitable for irregular wound cavities. They are commonly used in dental and oral surgeries, as well as neurosurgery and cardiovascular surgery. Matrix & gel hemostats provide rapid clot formation in hard-to-reach areas, whereas powder hemostats offer easy application across surgical specialties. Sheet & pad hemostats conform to irregular wound surfaces covering larger areas; then, sponge hemostats provide excellent absorbency and moldability for irregular wound cavities.

Application: Significant role of hemostats in cardiovascular surgeries to prevent blood loss and ensure successful outcomes

Cardiovascular surgeries involve high blood flow, arteries, and veins, often requiring efficient hemostatic solutions to prevent excessive bleeding. Hemostats are widely preferred in these procedures due to their rapid action and ability to achieve effective hemostasis. In general surgery, the use of hemostats plays a significant role in wound management and ensuring minimum blood loss during procedures such as appendectomy and hernia repair. Gynecological surgeries often require meticulous control of bleeding during delicate procedures such as hysterectomy and myomectomy. Hemostats have effectively minimized adhesions while providing adequate hemostasis during these surgeries. Hemostats are specifically designed to address this need while preserving neural structures. Orthopedic surgeries, including joint replacements and fracture fixation, require robust hemostatic agents as they involve cutting through dense bone and connective tissues. In reconstructive surgery, which includes skin grafting and flap reconstruction, managing blood loss becomes critical for successful outcomes. Hemostatic agents are preferred in these cases due to their adaptability across different tissues and ability to seal large wounds effectively. Compared to other applications, cardiovascular surgeries show a higher need-based preference for advanced hemostatic agents.

Regional Insights

The growing number of surgical procedures with the rising availability of advanced healthcare facilities, especially across the U.S., Canada, and Brazil, are expanding the growth of the hemostats market in the Americas. According to the American Society of Plastic Surgeons, in 2022, a total of 1,017,003 reconstructive surgeries were performed, necessitating the use of hemostats. The emerging trend of medical tourism across Canada, Dubai, Singapore, Japan, and the UK is expanding the number of minimally invasive surgical procedures, thereby creating a platform for the hemostats market. According to the Medical Tourism Index survey (MTA), Canada is one of the preferred destinations, attracting around 14 million Americans from other nations. Ongoing advancements in healthcare infrastructure and technologies across European countries, with constant support from regulatory bodies such as the European Medicines Agency (EMA) on expanding the manufacturing of medical devices and healthcare infrastructure, are bolstering the European market. The Middle East & Africa region presents promising growth opportunities due to increasing healthcare expenditure and government initiatives towards modernizing healthcare infrastructure. Countries, including Saudi Arabia, the United Arab Emirates, and South Africa, are witnessing a surge in the need for effective hemostatic solutions with the rising number of surgical interventions. Moreover, increased government funding to expand the manufacturing of medical devices domestically across India, Australia, China, and Japan and increased awareness associated with minimally invasive surgeries are expected to bolster market growth in Asia-Pacific.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Hemostats Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Hemostats Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Hemostats Market, highlighting leading vendors and their innovative profiles. These include A.R. Medicom, Inc., ACTEON Group, Advamedica Inc., Advanced Medical Solutions Group PLC, Advin Health Care, Aegis Lifesciences Private Limited, Argon Medical Devices, B. Braun SE, Baxter International Inc., Becton, Dickinson and Company, Betatech Medical, Convatec Group PLC, Cook Group Incorporated, Cortis Medtech Pvt Ltd, Cotran Corporation, Dolphin Sutures by Futura Surgicare Pvt. Ltd., Dynarex Corporation, Gelita AG, Hangzhou Singclean Medical Products Co.,Ltd., Healthium Medtech Ltd, Hemostasis, LLC, Integra LifeSciences Holdings Corporation, Johnson & Johnson Services, Inc., Medcura, Inc., Medline Industries, LP, Medprin Biotech GmbH, Medtronic PLC, Meril Life Sciences Pvt. Ltd., Olympus Corporation, Pfizer Inc., Rousselot BV by Darling Ingredients International Holding B.V., Royal DSM, Shilpa Medicare Limited, Stapleline Medizintechnik GmbH, Stryker Corporation, SYMATESE, Teleflex Incorporated, Terumo Corporation, Zhejiang Perfectseal New Material Technology Co., Ltd., and Zimmer Biomet Holdings, Inc..

Market Segmentation & Coverage

This research report categorizes the Hemostats Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Type
    • Collagen-Based Hemostats
    • Combination Hemostats
    • Gelatin-Based Hemostats
    • Oxidized Regenerated Cellulose-Based Hemostats
    • Thrombin-Based Hemostats
  • Formulation
    • Matrix & Gel Hemostats
    • Powder Hemostats
    • Sheet & Pad Hemostats
    • Sponge Hemostats
  • Application
    • Cardiovascular Surgery
    • General Surgery
    • Gynecological Surgery
    • Neurological Surgery
    • Orthopedic Surgery
    • Reconstructive Surgery
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Hemostats Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Hemostats Market?

3. What are the technology trends and regulatory frameworks in the Hemostats Market?

4. What is the market share of the leading vendors in the Hemostats Market?

5. Which modes and strategic moves are suitable for entering the Hemostats Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Prevalence of chronic disorders with increasing need for surgical interventions
      • 5.1.1.2. Growing inclination toward minimally invasive surgeries
    • 5.1.2. Restraints
      • 5.1.2.1. Rising incidences of product recalls
    • 5.1.3. Opportunities
      • 5.1.3.1. Rise of biopolymer-based disposable hemostats
      • 5.1.3.2. Integration of nanotechnology to create more efficient and targeted hemostats
    • 5.1.4. Challenges
      • 5.1.4.1. Risk of infection and cross contamination associated with the use of hemostats tools and reagents
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Type: Expanding the use of combination hemostats owing to their enhanced effectiveness in minimizing bleeding
    • 5.2.2. Formulation: Growing potential of powder hemostats for controlling and preventing bleeding during surgical intervention
    • 5.2.3. Application: Significant role of hemostats in cardiovascular surgeries to prevent blood loss and ensure successful outcomes
  • 5.3. Market Disruption Analysis
  • 5.4. Porter's Five Forces Analysis
    • 5.4.1. Threat of New Entrants
    • 5.4.2. Threat of Substitutes
    • 5.4.3. Bargaining Power of Customers
    • 5.4.4. Bargaining Power of Suppliers
    • 5.4.5. Industry Rivalry
  • 5.5. Value Chain & Critical Path Analysis
  • 5.6. Pricing Analysis
  • 5.7. Technology Analysis
  • 5.8. Patent Analysis
  • 5.9. Trade Analysis
  • 5.10. Regulatory Framework Analysis

6. Hemostats Market, by Type

  • 6.1. Introduction
  • 6.2. Collagen-Based Hemostats
  • 6.3. Combination Hemostats
  • 6.4. Gelatin-Based Hemostats
  • 6.5. Oxidized Regenerated Cellulose-Based Hemostats
  • 6.6. Thrombin-Based Hemostats

7. Hemostats Market, by Formulation

  • 7.1. Introduction
  • 7.2. Matrix & Gel Hemostats
  • 7.3. Powder Hemostats
  • 7.4. Sheet & Pad Hemostats
  • 7.5. Sponge Hemostats

8. Hemostats Market, by Application

  • 8.1. Introduction
  • 8.2. Cardiovascular Surgery
  • 8.3. General Surgery
  • 8.4. Gynecological Surgery
  • 8.5. Neurological Surgery
  • 8.6. Orthopedic Surgery
  • 8.7. Reconstructive Surgery

9. Americas Hemostats Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Hemostats Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Hemostats Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Teleflex Receives FDA Clearance for Expanded Indication for QuikClot Control+ Hemostatic Device Usage in Cardiac Surgical Procedures
    • 12.3.2. Baxter Launches PERCLOT Absorbable Hemostatic Powder
    • 12.3.3. Artivion Gains FDA Approval for PerClot, Starts Transfer to Baxter
    • 12.3.4. Olympus Europa SE & Co. KG Expands Endoclot Partnership with Endoclot to Launch Hemostatic Agents
    • 12.3.5. Darling Ingredients Completes Acquisition of Brazilian Gelatin and Collagen Producer Gelnex
    • 12.3.6. Chitosan-Based Hemostat For Controlling Severe Surgical Bleeding Gets FDA Clearance
    • 12.3.7. Advamedica Inc Announces FDA Clearance for Ax-Surgi Surgical Hemostat
    • 12.3.8. Medcura, Inc. Receives Breakthrough Device Designation for its LifeGel Absorbable Surgical Hemostat
    • 12.3.9. Medtronic plc Nexpowder Endoscopic Hemostasis System Receives U.S. FDA Clearance
    • 12.3.10. Hemostasis LLC Closes Acquisition of Fiagon Medical Technologies
  • 12.4. Strategy Analysis & Recommendation

13. Competitive Portfolio

  • 13.1. Key Company Profiles
  • 13.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. HEMOSTATS MARKET RESEARCH PROCESS
  • FIGURE 2. HEMOSTATS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL HEMOSTATS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL HEMOSTATS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL HEMOSTATS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. HEMOSTATS MARKET DYNAMICS
  • FIGURE 7. GLOBAL HEMOSTATS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL HEMOSTATS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL HEMOSTATS MARKET SIZE, BY FORMULATION, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL HEMOSTATS MARKET SIZE, BY FORMULATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL HEMOSTATS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL HEMOSTATS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. AMERICAS HEMOSTATS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 14. AMERICAS HEMOSTATS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES HEMOSTATS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 16. UNITED STATES HEMOSTATS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. ASIA-PACIFIC HEMOSTATS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. ASIA-PACIFIC HEMOSTATS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA HEMOSTATS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA HEMOSTATS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. HEMOSTATS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 22. HEMOSTATS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. HEMOSTATS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL HEMOSTATS MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL HEMOSTATS MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL HEMOSTATS MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL HEMOSTATS MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL HEMOSTATS MARKET SIZE, BY COLLAGEN-BASED HEMOSTATS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL HEMOSTATS MARKET SIZE, BY COLLAGEN-BASED HEMOSTATS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL HEMOSTATS MARKET SIZE, BY COMBINATION HEMOSTATS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL HEMOSTATS MARKET SIZE, BY COMBINATION HEMOSTATS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL HEMOSTATS MARKET SIZE, BY GELATIN-BASED HEMOSTATS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL HEMOSTATS MARKET SIZE, BY GELATIN-BASED HEMOSTATS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL HEMOSTATS MARKET SIZE, BY OXIDIZED REGENERATED CELLULOSE-BASED HEMOSTATS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL HEMOSTATS MARKET SIZE, BY OXIDIZED REGENERATED CELLULOSE-BASED HEMOSTATS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL HEMOSTATS MARKET SIZE, BY THROMBIN-BASED HEMOSTATS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL HEMOSTATS MARKET SIZE, BY THROMBIN-BASED HEMOSTATS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL HEMOSTATS MARKET SIZE, BY MATRIX & GEL HEMOSTATS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL HEMOSTATS MARKET SIZE, BY MATRIX & GEL HEMOSTATS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL HEMOSTATS MARKET SIZE, BY POWDER HEMOSTATS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL HEMOSTATS MARKET SIZE, BY POWDER HEMOSTATS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL HEMOSTATS MARKET SIZE, BY SHEET & PAD HEMOSTATS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL HEMOSTATS MARKET SIZE, BY SHEET & PAD HEMOSTATS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL HEMOSTATS MARKET SIZE, BY SPONGE HEMOSTATS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL HEMOSTATS MARKET SIZE, BY SPONGE HEMOSTATS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 31. GLOBAL HEMOSTATS MARKET SIZE, BY CARDIOVASCULAR SURGERY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 32. GLOBAL HEMOSTATS MARKET SIZE, BY CARDIOVASCULAR SURGERY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 33. GLOBAL HEMOSTATS MARKET SIZE, BY GENERAL SURGERY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 34. GLOBAL HEMOSTATS MARKET SIZE, BY GENERAL SURGERY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 35. GLOBAL HEMOSTATS MARKET SIZE, BY GYNECOLOGICAL SURGERY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 36. GLOBAL HEMOSTATS MARKET SIZE, BY GYNECOLOGICAL SURGERY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 37. GLOBAL HEMOSTATS MARKET SIZE, BY NEUROLOGICAL SURGERY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 38. GLOBAL HEMOSTATS MARKET SIZE, BY NEUROLOGICAL SURGERY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 39. GLOBAL HEMOSTATS MARKET SIZE, BY ORTHOPEDIC SURGERY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 40. GLOBAL HEMOSTATS MARKET SIZE, BY ORTHOPEDIC SURGERY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 41. GLOBAL HEMOSTATS MARKET SIZE, BY RECONSTRUCTIVE SURGERY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 42. GLOBAL HEMOSTATS MARKET SIZE, BY RECONSTRUCTIVE SURGERY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 43. AMERICAS HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 44. AMERICAS HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 45. AMERICAS HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 46. AMERICAS HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 47. AMERICAS HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 48. AMERICAS HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 49. AMERICAS HEMOSTATS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 50. AMERICAS HEMOSTATS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 51. ARGENTINA HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 52. ARGENTINA HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 53. ARGENTINA HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 54. ARGENTINA HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 55. ARGENTINA HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 56. ARGENTINA HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 57. BRAZIL HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 58. BRAZIL HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 59. BRAZIL HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 60. BRAZIL HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 61. BRAZIL HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 62. BRAZIL HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 63. CANADA HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 64. CANADA HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 65. CANADA HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 66. CANADA HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 67. CANADA HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 68. CANADA HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 69. MEXICO HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 70. MEXICO HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 71. MEXICO HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 72. MEXICO HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 73. MEXICO HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 74. MEXICO HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 75. UNITED STATES HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 76. UNITED STATES HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 77. UNITED STATES HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 78. UNITED STATES HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 79. UNITED STATES HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 80. UNITED STATES HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 81. UNITED STATES HEMOSTATS MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 82. UNITED STATES HEMOSTATS MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 83. ASIA-PACIFIC HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 84. ASIA-PACIFIC HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 85. ASIA-PACIFIC HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 86. ASIA-PACIFIC HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 87. ASIA-PACIFIC HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 88. ASIA-PACIFIC HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 89. ASIA-PACIFIC HEMOSTATS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 90. ASIA-PACIFIC HEMOSTATS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 91. AUSTRALIA HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 92. AUSTRALIA HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 93. AUSTRALIA HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 94. AUSTRALIA HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 95. AUSTRALIA HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 96. AUSTRALIA HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 97. CHINA HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 98. CHINA HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 99. CHINA HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 100. CHINA HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 101. CHINA HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 102. CHINA HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 103. INDIA HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 104. INDIA HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 105. INDIA HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 106. INDIA HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 107. INDIA HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 108. INDIA HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 109. INDONESIA HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 110. INDONESIA HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 111. INDONESIA HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 112. INDONESIA HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 113. INDONESIA HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 114. INDONESIA HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 115. JAPAN HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 116. JAPAN HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 117. JAPAN HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 118. JAPAN HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 119. JAPAN HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 120. JAPAN HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 121. MALAYSIA HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 122. MALAYSIA HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 123. MALAYSIA HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 124. MALAYSIA HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 125. MALAYSIA HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 126. MALAYSIA HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 127. PHILIPPINES HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 128. PHILIPPINES HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 129. PHILIPPINES HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 130. PHILIPPINES HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 131. PHILIPPINES HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 132. PHILIPPINES HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 133. SINGAPORE HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 134. SINGAPORE HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 135. SINGAPORE HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 136. SINGAPORE HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 137. SINGAPORE HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 138. SINGAPORE HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 139. SOUTH KOREA HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 140. SOUTH KOREA HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 141. SOUTH KOREA HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 142. SOUTH KOREA HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 143. SOUTH KOREA HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 144. SOUTH KOREA HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 145. TAIWAN HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 146. TAIWAN HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 147. TAIWAN HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 148. TAIWAN HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 149. TAIWAN HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 150. TAIWAN HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 151. THAILAND HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 152. THAILAND HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 153. THAILAND HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 154. THAILAND HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 155. THAILAND HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 156. THAILAND HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 157. VIETNAM HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 158. VIETNAM HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 159. VIETNAM HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 160. VIETNAM HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 161. VIETNAM HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 162. VIETNAM HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 163. EUROPE, MIDDLE EAST & AFRICA HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 164. EUROPE, MIDDLE EAST & AFRICA HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 165. EUROPE, MIDDLE EAST & AFRICA HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 166. EUROPE, MIDDLE EAST & AFRICA HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 167. EUROPE, MIDDLE EAST & AFRICA HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 168. EUROPE, MIDDLE EAST & AFRICA HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 169. EUROPE, MIDDLE EAST & AFRICA HEMOSTATS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 170. EUROPE, MIDDLE EAST & AFRICA HEMOSTATS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 171. DENMARK HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 172. DENMARK HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 173. DENMARK HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 174. DENMARK HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 175. DENMARK HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 176. DENMARK HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 177. EGYPT HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 178. EGYPT HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 179. EGYPT HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 180. EGYPT HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 181. EGYPT HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 182. EGYPT HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 183. FINLAND HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 184. FINLAND HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 185. FINLAND HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 186. FINLAND HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 187. FINLAND HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 188. FINLAND HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 189. FRANCE HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 190. FRANCE HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 191. FRANCE HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 192. FRANCE HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 193. FRANCE HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 194. FRANCE HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 195. GERMANY HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 196. GERMANY HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 197. GERMANY HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 198. GERMANY HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 199. GERMANY HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 200. GERMANY HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 201. ISRAEL HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 202. ISRAEL HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 203. ISRAEL HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 204. ISRAEL HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 205. ISRAEL HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 206. ISRAEL HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 207. ITALY HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 208. ITALY HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 209. ITALY HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 210. ITALY HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 211. ITALY HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 212. ITALY HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 213. NETHERLANDS HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 214. NETHERLANDS HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 215. NETHERLANDS HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 216. NETHERLANDS HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 217. NETHERLANDS HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 218. NETHERLANDS HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 219. NIGERIA HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 220. NIGERIA HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 221. NIGERIA HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 222. NIGERIA HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 223. NIGERIA HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 224. NIGERIA HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 225. NORWAY HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 226. NORWAY HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 227. NORWAY HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 228. NORWAY HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 229. NORWAY HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 230. NORWAY HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 231. POLAND HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 232. POLAND HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 233. POLAND HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 234. POLAND HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 235. POLAND HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 236. POLAND HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 237. QATAR HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 238. QATAR HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 239. QATAR HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 240. QATAR HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 241. QATAR HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 242. QATAR HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 243. RUSSIA HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 244. RUSSIA HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 245. RUSSIA HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 246. RUSSIA HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 247. RUSSIA HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 248. RUSSIA HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 249. SAUDI ARABIA HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 250. SAUDI ARABIA HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 251. SAUDI ARABIA HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 252. SAUDI ARABIA HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 253. SAUDI ARABIA HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 254. SAUDI ARABIA HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 255. SOUTH AFRICA HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 256. SOUTH AFRICA HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 257. SOUTH AFRICA HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 258. SOUTH AFRICA HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 259. SOUTH AFRICA HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 260. SOUTH AFRICA HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 261. SPAIN HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 262. SPAIN HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 263. SPAIN HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 264. SPAIN HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 265. SPAIN HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 266. SPAIN HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 267. SWEDEN HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 268. SWEDEN HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 269. SWEDEN HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 270. SWEDEN HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 271. SWEDEN HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 272. SWEDEN HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 273. SWITZERLAND HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 274. SWITZERLAND HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 275. SWITZERLAND HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 276. SWITZERLAND HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 277. SWITZERLAND HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 278. SWITZERLAND HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 279. TURKEY HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 280. TURKEY HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 281. TURKEY HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 282. TURKEY HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 283. TURKEY HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 284. TURKEY HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 285. UNITED ARAB EMIRATES HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 286. UNITED ARAB EMIRATES HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 287. UNITED ARAB EMIRATES HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 288. UNITED ARAB EMIRATES HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 289. UNITED ARAB EMIRATES HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 290. UNITED ARAB EMIRATES HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 291. UNITED KINGDOM HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 292. UNITED KINGDOM HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 293. UNITED KINGDOM HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 294. UNITED KINGDOM HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 295. UNITED KINGDOM HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 296. UNITED KINGDOM HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 297. HEMOSTATS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 298. HEMOSTATS MARKET, FPNV POSITIONING MATRIX, 2023